Silverarc Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-265,032
| Closed | -$2.71M | – | 82 |
|
|
2023
Q1 | $2.71M | Buy |
265,032
+35,616
| +16% | +$364K | 1.12% | 30 |
|
|
2022
Q4 | $2.42M | Buy |
229,416
+4,861
| +2% | +$51.3K | 0.69% | 44 |
|
|
2022
Q3 | $2.88M | Buy |
224,555
+11,465
| +5% | +$147K | 0.97% | 28 |
|
|
2022
Q2 | $2.73M | Buy |
+213,090
| New | +$2.73M | 0.84% | 24 |
|
|
2021
Q3 | – | Sell |
-75,732
| Closed | -$1.95K | – | 86 |
|
|
2021
Q2 | $1.95K | Buy |
+75,732
| New | +$1.95K | 0.87% | 39 |
|